According to IMARC Group’s latest report, titled “Meningococcal Vaccines Market Share: Industry Trends, Size, Growth, Opportunity and Forecast 2021-2026,” the global meningococcal vaccines market reached a value of US$ 2.8 Billion in 2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 9.5% during 2021-2026.
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
The meningococcal vaccine includes a biological substance formulated to prevent meningitis that occurs when the liquid surrounding the brain and spinal cords become infected. The meningococcal vaccines can broadly be categorized into conjugate, polysaccharide, and subcapsular meningococcal vaccines. They are widely administered to infants, children and adults to immunize them against invasive ailments and meningococcal bacteria. Once the vaccine is dispensed, antibodies are formed to fight the bacteria and create an immune response to preclude the infection in the future.
Request Free Sample Report: https://www.imarcgroup.com/meningococcal-vaccines-market/requestsample
The growing prevalence of meningococcal diseases is primarily driving the market for meningococcal vaccines. Furthermore, the increasing health consciousness among the masses and the rising adoption of routine immunization are also positively influencing the market. The meningococcal vaccine helps in preventing the disease and minimizing the long-term effects, such as neurological damage, temporary or permanent deafness, and loss of vision and motor skills. Additionally, the government bodies across various nations are launching extensive public health programs for focusing on the immunization of special risk groups, such as tourists and military personnel, to contain the spread of infections. All of the above-mentioned factors will continue to drive the market for meningococcal vaccines in the coming years.
Ask Analyst and Browse Full Report with TOC & List of Figure: https://www.imarcgroup.com/meningococcal-vaccines-market
List of Key Companies Covered in this Market Report:
Hualan Biological Engineering Inc.
Incepta Pharmaceuticals Limited
Serum Institute of India Ltd.
Walvax Biotechnology Co. Ltd.
The report has segmented the market on the basis of vaccine type, composition, vaccine serotype, distribution channel, end-user and geography.
Breakup by Vaccine Type:
Breakup by Composition:
Breakup by Vaccine Serotype:
MenB & Manic
Breakup by Distribution Channel:
Breakup by End User:
Breakup by Geography:
North America (U.S. & Canada)
Europe (Germany, United Kingdom, France, Italy, Spain, Russia, and Others)
Asia Pacific (China, India, Japan, South Korea, Indonesia, Australia, and Others)
Latin America (Brazil, Mexico)
Middle East & Africa
Also read latest blog Top Foreign Exchange Companies
Key highlights of the report:
Market Performance (2015-2025)
Market Outlook (2021- 2026)
Porter’s Five Forces Analysis
Market Drivers and Success Factors
Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
Related Report by IMARC Group:
Artificial Intelligence in Healthcare Market Report: https://www.imarcgroup.com/artifical-intelligence-healthcare-market
Guidewires Market Report: https://www.imarcgroup.com/guidewires-market
Remote Patient Monitoring Market Report: https://www.imarcgroup.com/remote-patient-monitorning-market
Hemostats Market Report: https://www.imarcgroup.com/hemostats-market
Hospital Information System Market Report: https://www.imarcgroup.com/hospital-information-system-market
Hernia Repair Market Report: https://www.imarcgroup.com/hernia-repair-market
Spa Market Report: https://www.imarcgroup.com/spa-market
Capnography Devices Market Report: https://www.imarcgroup.com/capnography-devices-market
Intracranial Pressure Monitoring Market Report: https://www.imarcgroup.com/intracranial-pressure-monitoring-market
Vital Signs Monitoring Devices Market Report: https://www.imarcgroup.com/vital-signs-monitoring-devices-market
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
IMARC Group 30 N Gould St Ste R Sheridan, WY 82801 USA – Wyoming Email: Sales@imarcgroup.com Tel No:(D) +91 120 433 0800 Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Tel No:(D) +91 120 433 0800 Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800